A nanogel of a naturally occurring anticancer compound called triptolide coated with folate could be used to treat hepatocellular carcinoma, the most common form of primary liver cancer. So say researchers from Korea and Singapore who have found that the compound can be selectively taken up by tumour cells and once there lose its coating, so effectively destroying these cells….
http://nanotechweb.org/cws/article/tech/58237